Loading clinical trials...
Loading clinical trials...
A Multicenter Study to Obtain Data to Assist in Radiation Dosimetry Calculations From Subjects Enrolled in Human Studies Employing 18F-AV-1451
This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Molecular NeuroImaging
New Haven, Connecticut, United States
Start Date
January 1, 2015
Primary Completion Date
June 1, 2015
Completion Date
June 1, 2015
Last Updated
August 11, 2020
6
ACTUAL participants
Flortaucipir F18
DRUG
Lead Sponsor
Avid Radiopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07033494